用 Vasculotide 进行暴露前预防,提高生存率,缓解致命全身辐射后的造血和胃肠道损伤
Li Wang1,2,3, Bin Lin1,2, Min Zhai1,2
1Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
International journal of molecular sciences
|February 27, 2026
概括
Vasculotide (VT) 显示出作为急性辐射综合征 (ARS) 暴露前预防的前兆. 这种Tie2激动剂模仿显著提高了小鼠的生存率,并保护它们免受辐射诱导的血管和器官损伤.
科学领域:
- 辐射生物学 辐射生物学
- 药理学 药理学是指药理学的学科.
- 血管生物学 血管生物学
背景情况:
- 由于没有FDA批准的预防治疗方法,急性辐射综合征 (ARS) 构成重大威胁.
- 辐射暴露会损害血管内皮,这是导致ARS的关键目标.
- 现有的ARS医疗对策是有限的.
研究的目的:
- 调查 Vasculotide (VT),一个Tie2受体激素模仿剂,作为ARS的新型暴露前预防.
- 评估VT在稳定血管内皮和减轻辐射引起的损伤方面的有效性.
- 评估VT对全身辐射后的生存率和器官恢复的影响.
主要方法:
- 雌性B6D2F1/J小鼠接受了9.5 Gy的全身辐射 (TBI).
- 在TBI发生前12个小时和2个小时内,Vasculotide (VT) 进行皮下注射.
- 评估结果包括30天的生存期,血管损伤生物标志物,细胞因子/化学因子概况和血液生成/胃肠道恢复.
主要成果:
- 静脉治疗显著增加了剂量依赖的30天生存率,在20μg/kg时生存率优势为30%.
- 静脉疗法证明了对辐射诱导的血管激活和损伤的强有力的保护.
- 静脉疗法有效地缓解了骨髓和胃肠道的损伤.
结论:
- Vasculotide (VT) 被确定为急性辐射综合征 (ARS) 的有希望的预防性对策.
- VT的机制包括准Tie2通道,以保持血管完整性.
- 在放射性情景中,VT提供了一种可行的策略,以提高存活率和加速多器官恢复.
关键词:
30天的生存率是30天的生存率一致2路径的路径.血管胺是一种血管胺.急性辐射综合征是什么造血和胃肠道的恢复.有关炎症的细胞因子/化学因子.预防 预防 预防 预防整个身体的辐射辐射.血管激活和损伤的发生.血管内皮的血管内皮.更多相关视频
09:09A Modified Heterotopic Swine Hind Limb Transplant Model for Translational Vascularized Composite Allotransplantation VCA Research
Published on: October 14, 2013
12.9K
08:55Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
Published on: April 15, 2016
10.0K
相关概念视频
01:27Tumor Immunotherapy
2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K
01:29Venous Thrombosis III: Interprofessional Care
482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482